BRCA1 and BRCA2

Article Abstract:

A task force convened by the Cancer Genetics Studies Consortium has published recommendations for women who carry the BRCA gene mutations. Mutations in the BRCA1 and BRCA2 genes have been linked to familial breast and ovarian cancer. Women who test positive for the mutations should begin breast self-examination at age 18-21 and should have annual mammograms and physician exams at age 25-35. Annual screening for ovarian cancer should include transvaginal ultrasound and testing for the CA-125 tumor marker. There is no evidence that removing the breasts or ovaries can prevent the development of cancer.

Standards, Medical screening, Health screening

---

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer

Article Abstract:

The relationship between race and the use of BRCA1/2 counseling among women with a family history of breast or ovarian cancer is investigated. Results revealed large racial disparities where among women with a family history of breast or ovarian cancer, women who underwent BRCA1/2 counseling (cases) were significantly less likely to be American than women who did not undergo BRCA1/2 counseling.

United States, Management dynamics, Management, Diagnosis, Women, Women's health, Company business management, Genetic counseling, Genetic counselling

---

Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both

Article Abstract:

Women with a mutation in the BRCA1 gene may be more likely to give birth to girls than boys, according to a study of 68 families with a history of breast or ovarian cancer. BRCA1 gene mutations have been linked to some types of hereditary breast or ovarian cancer. This study shows that they may also cause more girls to be born than boys.

Sex ratio

Similar abstracts:

• Abstracts: Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer
• Abstracts: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. Breast cancer genetics: what we know and what we need
• Abstracts: A real chance to engage with people. The North West has it all for nurses. Living and working in East Anglia
• Abstracts: Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction
• Abstracts: Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.